Stratec SE/€SBS

05:30
09:10
12:45
16:25
20:00
1D1W1MYTD1Y5YMAX

About Stratec SE

**Stratec SE** is a German-based company specializing in the development and manufacturing of laboratory automation systems and diagnostics equipment. Primarily operating within the healthcare sector, its key offerings include modular and integrated systems, software solutions, and smart consumables designed to enhance laboratory workflows. Founded in 1979, Stratec has headquarters in Birkenfeld, Germany, and serves a global clientele. The company's strategic advantage lies in its ability to deliver custom OEM solutions tailored to specific partner requirements, ensuring seamless integration into existing laboratory processes. Stratec's collaboration with leading in-vitro diagnostics companies underscores its capability in providing sophisticated technological solutions.

Ticker

€SBS

Primary listing

XETRA

Industry

Health Care Equipment & Supplies

Employees

1,387

ISIN

DE000STRA555

Stratec SE Metrics

BasicAdvanced
€326M
20.32
€1.32
0.49
€0.60
2.24%

Bulls say / Bears say

Stratec SE's acquisition of Natech Plastics in July 2023 enhances its capabilities in producing complex polymer-based consumables, potentially expanding its market reach and product offerings. (Simply Wall St)
The company announced a dividend of €0.55 per share, payable on July 2, 2025, indicating a commitment to returning value to shareholders. (Simply Wall St)
Stratec SE received validation of its climate targets from the Science Based Targets initiative (SBTi) in March 2025, reflecting its commitment to sustainable practices, which may attract ESG-focused investors. (Stock Analysis)
Stratec SE was delisted from the Germany SDAX (Total Return) Index on May 9, 2025, due to the delayed submission of audited financial reports, which may raise concerns about financial transparency. (Simply Wall St)
The company reported a significant decline in earnings per share (EPS) for Q3 2024, with €0.045 compared to €0.42 in Q3 2023, indicating potential profitability challenges. (Simply Wall St)
Stratec SE's stock price has declined by approximately 48.86% over the past year, reflecting potential investor concerns about the company's performance and outlook. (Simply Wall St)
Data summarised monthly by Lightyear AI. Last updated on 1 Jul 2025.
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.

Buy €SBS

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events
FAQs